加味黄芪桂枝五物汤治疗0-1级糖尿病足的临床研究
[Abstract]:Aim: diabetic foot (Diabetic Foot,DF) is one of the serious chronic complications of diabetes mellitus. It has high disability and treatment cost, which seriously reduces the quality of life of the patients. The purpose of this study was to observe the clinical efficacy of modified Huangqi Guizhi Wuwu decoction in the treatment of 0 ~ 1 grade DF, to explore the effective methods for the treatment of early stage DF, to greatly reduce the possibility of its development to the later stage of DF, and to promote wound healing in patients with DF. Its meaning is: 1. Giving full play to the advantages of simplicity, convenience, cheapness, efficiency and other advantages of traditional Chinese medicine can greatly lighten the economic burden of patients at the same time as it plays a therapeutic effect; 2. Reflect the thought of "cure no disease" of traditional Chinese medicine, make a good plan in advance, carry on effective Chinese medicine intervention in the early stage of DF, cut off the course of disease in time, greatly improve the quality of life of the patients; 3. This study provides an objective research material for the prevention of DF and DF, and lays a foundation for further research in the future. In this study, the therapeutic effect of modified Huangqi Guizhi Wuwu decoction on qi deficiency, blood stasis and skin choroidal obstruction was observed by digging the meridian formula and making use of the characteristics of pre-DF, in order to find a suitable recipe for treatment of DF. Methods: 51 inpatients in the Department of Endocrinology of the first affiliated Hospital of Guangzhou University of traditional Chinese Medicine were randomly divided into two groups: treatment group and control group. The difference of general basic data, such as gender, course of disease and so on, suggested that after the baseline of the two research groups was consistent and comparable, the treatment group was given modified Huangqi Guizhi Wuwu decoction during three weeks of study period, the treatment group was treated with modified Huangqi Guizhi Wuwu decoction. The control group took Mecobao tablets and intravenous injection of alprostadil. The indexes of FBG,2hPBG, hemorheology and ESR,ABI in the two groups were compared before and after treatment, and the whole body and foot symptoms before and after treatment were evaluated with reference to the whole body symptom scale and the foot symptom scale (see Appendix 3, 4). To evaluate the clinical efficacy of the two methods in the treatment of diabetic foot. All data were analyzed in computer with software SPSS22. The statistical data were counted by chi-square test or rank sum test. The units of measurement were expressed as mean 卤standard deviation (x 卤s), and the independent sample t-test was used between groups, and the statistical data were counted by chi-square test or rank-sum test. Paired sample t-test was used in the group, and non-parametric test was used in the group. There was significant difference between the two groups (P0.05), and there was a very significant difference between the two groups (P0.01). Results: through the comparison between the treatment group and the control group before and after treatment, it can be concluded that the prescription has no obvious therapeutic effect on the improvement of blood glucose, and the improvement degree of several indexes in the hemorheology of the prescription is more obvious than that of the simple western medicine treatment. The improvement of ABI was superior to that of western medicine group, and the improvement of TCM syndrome was better than that of western medicine group. Overall, the efficacy of the prescription in the treatment of grade 0 1 DF is better than that of the control group. Conclusion: according to the clinical results, the curative effect of this prescription is better than that of the control group in the pre-treatment of DF. It is worth further studying the clinical curative effect of the combination of traditional Chinese medicine and western medicine.
【学位授予单位】:广州中医药大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R259
【相似文献】
相关期刊论文 前10条
1 王玉新,李大启,李公宝,徐琴君;糖尿病肾病患者血清可溶性白细胞介素6受体检测[J];上海免疫学杂志;2001年02期
2 宫雅南,刘冬年,熊玉冰,黄伟文,庄万江;糖尿病足患者糖尿病视网膜病变分析[J];广东医学;2001年06期
3 顾芹,宋守君,李向阳,尤传一;胰激肽原酶肠溶片对早期糖尿病肾病的防治作用[J];中国临床药学杂志;2001年06期
4 曹爱华 ,王瑛 ,李翔;杏丁治疗早期糖尿病肾病疗效观察[J];辽宁实用糖尿病杂志;2001年03期
5 ;中药治疗糖尿病肾病新进展[J];中国中医药信息杂志;2001年04期
6 张桂茹;糖尿病肾病85例临床分析[J];陕西医学杂志;2002年02期
7 侯建明 ,林凤辉 ,张超群;46例2型糖尿病肾病与糖尿病自主神经病变的关系分析[J];福建医药杂志;2002年04期
8 陈文霖;糖尿病饮食[J];医疗保健器具;2002年Z1期
9 孙力,许玲;2型糖尿病患者糖尿病足的危险因素分析[J];山东医药;2002年35期
10 ;糖尿病肾病诊治研究进展[J];基础医学与临床;2003年04期
相关会议论文 前10条
1 张星;许筠;苏建平;张军;程立志;翟晓丽;;糖尿病肾病的临床疗效对比观察[A];第十九次全国中医肾病学术交流会论文汇编[C];2006年
2 杨家茂;;糖尿病肾病防治琐谈[A];全国第二届中医中西医结合肾脏病临床进展学术研讨会论文集[C];2007年
3 丁耀耿;郝桂霞;;糖尿病肾病临床分析[A];全国第二届中医中西医结合肾脏病临床进展学术研讨会论文集[C];2007年
4 张文铠;王志伏;王雪;孙大朋;;糖尿病肾病的治疗现状[A];中华中医药学会第二十一届全国中医肾病学术会议论文汇编(下)[C];2008年
5 倪青;;糖尿病肾病的中西医结合研究[A];第六届全国中西医结合肾脏病学术会议论文汇编[C];2000年
6 孙怡;李健红;宗红燕;;黄芪桂枝五物汤加味治疗糖尿病肾病16例[A];第六届全国中西医结合肾脏病学术会议论文汇编[C];2000年
7 叶军;;糖尿病肾病在儿童时期的早期干预[A];中华医学会第六次全国内分泌学术会议论文汇编[C];2001年
8 杜旭昶;孙志红;闫春芳;刘彩虹;;疏糖丹治疗2型糖尿病50例临床分析[A];第六次中国中西医结合糖尿病学术会议论文汇编[C];2002年
9 于世家;任平;马丽佳;李小娟;郑曙琴;武明东;刘自力;薛丽辉;;糖尿病住院患者1344例回顾性分析[A];第六次中国中西医结合糖尿病学术会议论文汇编[C];2002年
10 郝效槐;魏玫都;崔立俊;;中西并蓄治疗糖尿病肾病[A];第七次中国中西医结合糖尿病学术会议论文汇编[C];2004年
相关重要报纸文章 前10条
1 本报记者 向佳;糖尿病中医药防治项目立足社区[N];中国中医药报;2011年
2 特约记者 鲁海燕;逾八成公众存在糖尿病高危因素[N];家庭医生报;2013年
3 马明愈;现代生活方式导致 糖尿病发病率迅速上升[N];中国妇女报;2005年
4 省立医院内分泌科主任医师 侯建明;糖尿病肾病的防治[N];福建科技报;2004年
5 王文绢 范军星;世界糖尿病日关注焦点:糖尿病并发症[N];健康报;2003年
6 主持人 向红丁博士;糖尿病肾病须早防早治[N];人民政协报;2002年
7 华悦;预防糖尿病,,从减肥开始[N];上海中医药报;2004年
8 刘冬梅;肥胖糖尿病第一诱因[N];天津日报;2004年
9 刘燕玲;首部中医专病指南定下糖尿病治则[N];健康报;2007年
10 崔昕;中药防治糖尿病肾病有进展[N];健康时报;2006年
相关博士学位论文 前10条
1 王晓杰;组蛋白去乙酰化酶4特异性促进糖尿病肾病足细胞损伤[D];山东大学;2015年
2 张永;MiR-346在抗TGF-β信号途径介导的糖尿病肾病发生和发展中的作用机制[D];武汉大学;2015年
3 魏凤江;高尿酸血症、2型糖尿病及糖尿病微血管病变的群体遗传学研究[D];天津医科大学;2015年
4 孙士杰;胱抑素C对2型糖尿病视网膜病变预测价值研究[D];山东大学;2015年
5 魏艳红;PKCα介导的EGFR降解在糖尿病肾病足细胞损伤中的作用及机制[D];华中科技大学;2015年
6 龙泓竹;益气养阴通络散结方防治早期糖尿病肾病的临床及实验研究[D];北京中医药大学;2016年
7 姜e
本文编号:2466580
本文链接:https://www.wllwen.com/jingjilunwen/jiliangjingjilunwen/2466580.html